Xencor (XNCR) Non Operating Investment Income (2015 - 2023)

Xencor (XNCR) reported Non Operating Investment Income of $1.2 million for Q3 2023, up 228.89% year-over-year from $364859.6 in Q3 2022, and down 32.01% quarter-over-quarter from $1.8 million in Q2 2023.

Xencor (XNCR) Non Operating Investment Income (2015 - 2023) Analysis & Trends

Xencor (XNCR) has 9 years of Non Operating Investment Income data on file, last reported at $1.2 million in Q3 2023.

  • Non Operating Investment Income for Q3 2023 came in at $1.2 million, up 228.89% year-over-year; the trailing twelve-month figure through Sep 2023 was $9.2 million (up 194.44% YoY), and the FY2022 annual result was -$5.4 million, down 243.56% from the prior year.
  • Non Operating Investment Income fell to $1.2 million in Q3 2023 per XNCR's latest filing, from $1.8 million in the prior quarter.
  • Over five years, Non Operating Investment Income peaked at $3.3 million in Q1 2023 and troughed at -$5.6 million in Q1 2022.
  • A 5-year average of $18631.6 and a median of -$105000.0 in 2020 frame the typical range for Non Operating Investment Income.
  • The sharpest annual moves came in 2019 and 2022: Non Operating Investment Income jumped 565.28% in 2019, then sank 24447.83% in 2022.
  • A 5-year view of Non Operating Investment Income shows it stood at -$275000.0 in 2019, then sank by 79.27% to -$493000.0 in 2020, then slumped by 191.08% to -$1.4 million in 2021, then jumped by 306.13% to $3.0 million in 2022, then sank by 59.43% to $1.2 million in 2023.
  • Business Quant data shows XNCR's Non Operating Investment Income at $1.2 million in Q3 2023, $1.8 million in Q2 2023, and $3.3 million in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 235,807.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 230,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Xencor 953.38 Mn 878.64 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2023 1.20 Mn
Sep 30, 2023 1.20 Mn
Jun 30, 2023 1.77 Mn
Jun 30, 2023 1.77 Mn
Mar 31, 2023 3.30 Mn
Mar 31, 2023 3.30 Mn
Dec 31, 2022 2.96 Mn
Dec 31, 2022 2.96 Mn
Sep 30, 2022 -931,000.00
Sep 30, 2022 -931,000.00
Jun 30, 2022 -1.80 Mn
Jun 30, 2022 -1.80 Mn
Mar 31, 2022 -5.60 Mn
Mar 31, 2022 -5.60 Mn
Dec 31, 2021 -1.44 Mn
Dec 31, 2021 -1.44 Mn
Sep 30, 2021 -59,000.00
Sep 30, 2021 -59,000.00
Jun 30, 2021 -112,000.00
Jun 30, 2021 -112,000.00